Responsive Header Image
Header Image

Ruud Pijnappel

Ruud Pijnappel, MD, PhD is Professor (EM) of Breast Radiology at University MedicalCentre Utrecht; Utrecht University, The Netherlands. And past Chair of the Dutch ExpertCentre for Screening.Since 1996 Prof. Pijnappel main clinical and research interests include breast imaging,screening and intervention. Working with and teaching residents and fellow's the detailsof breast cancer screening and assessment in a multidisciplinary setting serves hisparticular interests.

Prof. Pijnappel is Past President of the Dutch College of Breast Imaging (DCBI) and since 2024 Past President of the EUSOBI.

Breast Imaging from past till present

This lecture will take you back in time to the last century when mammography was ‘born’. In fact, at that time the restrictions of 2D mammography already came forward. The presentation will take you on a journey that researchers and industry made to overcome the limitations of the original boundaries. From the transition of analogue to digital, the introduction of Tomosynthesis and the shift from anatomical to contrast based imaging. How successful these efforts were is highlighted. Recent technologies with the help of huge computers made the introduction of Artificial Intelligence a fact. Whether this will be the future or just a helping ‘hand’ will be discussed. One thing is for sure Breast Imaging is a dynamic and fast changing subspecialty, but despite this all the wellbeing of our patients remains in the centre of our scope.

How to arrive to a final diagnosis after initial imaging

The pathway from imaging to a final diagnosis can be very troublesome especially for the women involved. This lecture will highlight what we as breast imagers and interventionalists can do to minimize the discomfort and anxiety to patients when an abnormality is discovered on imaging. We should realise ourselves that a final diagnosis as shortly as possible after a discovered abnormality can not only take away a lot of anxiety but also has an influence on reattendance to the screening program. BIRADS-3 and therefore follow-up of a lesion is a no go in case of screening. We should always opt for a final diagnosis. The women have the right to know what the explanation is for the suspicious finding on imaging. Apart from that, knowledge about the risk of underestimation of image guided interventions, is obligatory to choose the right image guidance and biopsy technique to get an optimal pre-treatment diagnosis.  


Managed and payment processed by: 

KC Jones conference&events Ltd
Telephone: +44 (0)1332 227775
Email: bci@kc-jones.co.uk



Follow us online

Social Media Links